Q1. What clinical findings are likely in R.S. as a consequence of his COPD?
Ans. The clinical findings are likely in R.S. as consequences of his COPD are SOB, history of smoking, thick sputum and sputum may be purulent, productive cough, wheezing, rhonchi and decreased breath sounds, dyspnea, chills, muscle aches, fatigue may be evident during meals, when walking and even after rest. In chronic obstructive lung problems are known because resistance in airflow increases and causes obstruction in the walls of lumen. Patient must have had chronic or productive cough that would last for 3 months and then happen it again for at least 2 years or more. Chronic bronchitis is also known as type B COPD or the “blue bloater,” which is diagnosed symptomatically by hypersecretion of bronchial mucus and in R.S.’s clinical findings there is definitely signs of emphysema, airway obstruction is persistent and irreversible.
Q2. How would the consequences of the COPD of R.S. (identified in question 1) differ from those of emphysematous COPD? …show more content…
Theophylline has a longer acting and has anti-inflammatory effect, also appears to produce relatively constant levels of effect on airway responsiveness and clinical efficacy around the clock. Theophylline is use to prevent and treat wheezing, SOB, chronic bronchitis, emphysema and other lung diseases. In R.S.’s case it should be efficient because it helps open and relax air passages and makes it easier to breath. And B2 agonist is a shorter acting bronchodilator used for first defensive inhaler. You use B2 agonist first to open up the airways and then administer with Theophylline tablet to keep the airways open. Both are bronchodilators but theophylline is given if the first one, B2 agonist prescribed has not worked effectively on the patient. Bronchodilator therapy is given to reverse airway obstruction and to slow the rate of disease progression. Theophylline has been proven for many years to be more effective for treating
Ans. The clinical findings are likely in R.S. as consequences of his COPD are SOB, history of smoking, thick sputum and sputum may be purulent, productive cough, wheezing, rhonchi and decreased breath sounds, dyspnea, chills, muscle aches, fatigue may be evident during meals, when walking and even after rest. In chronic obstructive lung problems are known because resistance in airflow increases and causes obstruction in the walls of lumen. Patient must have had chronic or productive cough that would last for 3 months and then happen it again for at least 2 years or more. Chronic bronchitis is also known as type B COPD or the “blue bloater,” which is diagnosed symptomatically by hypersecretion of bronchial mucus and in R.S.’s clinical findings there is definitely signs of emphysema, airway obstruction is persistent and irreversible.
Q2. How would the consequences of the COPD of R.S. (identified in question 1) differ from those of emphysematous COPD? …show more content…
Theophylline has a longer acting and has anti-inflammatory effect, also appears to produce relatively constant levels of effect on airway responsiveness and clinical efficacy around the clock. Theophylline is use to prevent and treat wheezing, SOB, chronic bronchitis, emphysema and other lung diseases. In R.S.’s case it should be efficient because it helps open and relax air passages and makes it easier to breath. And B2 agonist is a shorter acting bronchodilator used for first defensive inhaler. You use B2 agonist first to open up the airways and then administer with Theophylline tablet to keep the airways open. Both are bronchodilators but theophylline is given if the first one, B2 agonist prescribed has not worked effectively on the patient. Bronchodilator therapy is given to reverse airway obstruction and to slow the rate of disease progression. Theophylline has been proven for many years to be more effective for treating